Original article
Thrombotic risk assessed by PAI-1 in patients with COVID-19: The influence of hyperglycemia and diabetes mellitus
Riesgo trombótico evaluado por PAI-1 en pacientes con COVID-19: la influencia de la hiperglucemia y la diabetes mellitus
Lourdes Basurtoa, Leticia Manuel-Apolinara,
, Ariadna Robledob, Sean O’Learyb, Carlos Martínez-Murilloc, Lina Ivette Medina-Ortíza, Mario German Montes Osoriod, Julio Zarazuaa, Lourdes Balcázar-Hernándeze, Juan Carlos Anda-Garayf
Corresponding author
a Endocrine Research Unit, Centro Medico Nacional Siglo XXI, IMSS, Av. Cuauhtémoc 330, Doctores, CP 06720 Mexico City, Mexico
b Department of Neurosurgery, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA
c Hematology Department, Hospital General de México, Dr. Balmis 148, Doctores, Cuauhtemoc, 06720 Mexico City, Mexico
d Nuclear Medicine Department, Hospital de Especialidades, Centro Medico Nacional Siglo XXI, IMSS, Av. Cuauhtémoc 330, Doctores, CP 06720 Mexico City, Mexico
e Endocrinology Department, Hospital de Especialidades, Centro Medico Nacional Siglo XXI, IMSS, Av. Cuauhtémoc 330, Doctores, CP 06720 Mexico City, Mexico
f Internal Medicine Department, Hospital de Especialidades, Centro Medico Nacional Siglo XXI, IMSS, Av. Cuauhtémoc 330, Doctores, CP 06720 Mexico City, Mexico
Read
941
Timeswas read the article
208
Total PDF
733
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 26 | 9 | 35 |
| 2025 11 | 135 | 47 | 182 |
| 2025 10 | 58 | 7 | 65 |
| 2025 9 | 41 | 40 | 81 |
| 2025 8 | 35 | 20 | 55 |
| 2025 7 | 50 | 18 | 68 |
| 2025 6 | 14 | 5 | 19 |
| 2025 5 | 34 | 6 | 40 |
| 2025 4 | 27 | 3 | 30 |
| 2025 3 | 24 | 4 | 28 |
| 2025 2 | 34 | 6 | 40 |
| 2025 1 | 61 | 2 | 63 |
| 2024 12 | 32 | 1 | 33 |
| 2024 11 | 27 | 2 | 29 |
| 2024 10 | 19 | 6 | 25 |
| 2024 9 | 26 | 7 | 33 |
| 2024 8 | 83 | 16 | 99 |
| 2024 7 | 7 | 9 | 16 |
Show all